Adjuvant apatinib following concurrent chemoradiotherapy in high-risk nasopharyngeal carcinoma: a multicenter, prospective, phase 2 study

Authors
Category Primary study
ConferenceJournal of clinical oncology
Year 2025
This article has no abstract
Epistemonikos ID: 9261d90627899fab21fc731024d92c5af45c07ad
First added on: Apr 04, 2026